Core Viewpoint - Yiming Pharmaceutical announced plans to purchase liability insurance for its directors and executives, with a compensation limit not exceeding 100 million yuan and a premium not exceeding 500,000 yuan for a duration of 12 months [2] Group 1 - The company intends to seek shareholder approval to authorize the management team to handle the insurance purchase and renewal matters [2]

证券代码：688061 证券简称：灿瑞科技 公告编号：2026-004 上海灿瑞科技股份有限公司 关于购买董事、高级管理人员责任险的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 为进一步完善上海灿瑞科技股份有限公司（以下简称"公司"）风险管理体系，降低公司运营风险，促进 公司董事、高级管理人员充分行使权利，履行职责和义务，保障广大投资者的利益，根据《中华人民共 和国公司法》《上市公司治理准则》等相关规定，公司拟为公司及公司全体董事、高级管理人员及相关 责任人员购买责任保险（以下简称"董高责任险"），现将有关事项公告如下： 一、董高责任险具体方案 （一）投保人：上海灿瑞科技股份有限公司； （二）被保险人：公司及全体董事、高级管理人员及相关责任人员（具体以保险合同约定为准）； （三）赔偿限额：不超过人民币5,000万元（具体以保险合同约定为准）； （四）保险费用：不超过人民币20万元（具体以保险合同约定为准）； （五）保险期限：一年（后续每年可续保或重新投保）； （六）投保授权：为提高决策效率，董事会同时提请股东会授权 ...

Core Viewpoint - China Uranium Industry announced the decision to purchase liability insurance for its directors and senior management, indicating a proactive approach to risk management and corporate governance [1] Group 1 - The first board meeting of the company will be held on January 22, 2026, to review the proposal for purchasing liability insurance [1] - The insurance will cover the company, its subsidiaries, and all directors and senior management [1]

Core Viewpoint - The company plans to purchase liability insurance for its directors and senior management, pending approval from the shareholders' meeting [2]. Group 1 - The company announced that it will hold the 13th meeting of the fourth board of directors on December 30, 2025 [2]. - The proposal to purchase liability insurance for directors and senior management has been approved by the board [2]. - The decision is subject to approval by the company's shareholders [2].

Core Viewpoint - The company is taking significant steps to enhance its compliance risk management system and ensure the safety of its management team by proposing to purchase Directors and Officers Liability Insurance (D&O Insurance) [1][2]. Group 1: Governance and Risk Management - The primary objective of purchasing D&O Insurance is to improve compliance and risk management mechanisms, thereby reducing operational risks and safeguarding the overall interests of the company [2]. - The decision to purchase D&O Insurance reflects the company's commitment to protecting the rights of minority shareholders and adhering to regulatory requirements for listed companies [4]. Group 2: Implementation and Authorization - The insurance plan will cover all directors, senior management, and other relevant responsible personnel, with specific details to be determined through negotiations with the insurance company [3]. - The board has requested authorization from the shareholders' meeting to empower the management team to handle specific matters related to the insurance purchase, including selecting the insurance company and determining coverage limits [3]. Group 3: Decision-Making Process - During the deliberation of the proposal, all board members recused themselves from voting due to their status as potential beneficiaries, demonstrating adherence to the company's governance protocols [4]. - The company plans to expedite the implementation of the insurance purchase following approval from the shareholders' meeting and will provide timely updates on the progress [4].

Group 1 - The company announced the decision to purchase liability insurance for its directors and senior management to enhance its risk management system [2] - The board and supervisory committee meetings were held on November 18, 2025, where the proposal was approved [2] - The purpose of the liability insurance is to ensure that directors and senior management can perform their duties fully while reducing operational risks and protecting the interests of investors [2]

Core Viewpoint - Dahua Technology announced plans to purchase liability insurance for the company and all directors, senior management, and related responsible personnel [2] Group 1 - The announcement was made on the evening of November 7 [2] - The insurance purchase aims to cover potential liabilities for the company and its key personnel [2]